These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7606918)

  • 21. Subnormal retinal oxygenation response precedes diabetic-like retinopathy.
    Berkowitz BA; Kowluru RA; Frank RN; Kern TS; Hohman TC; Prakash M
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2100-5. PubMed ID: 10440266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinal vessel changes in galactose-fed dogs.
    Kobayashi T; Kubo E; Takahashi Y; Kasahara T; Yonezawa H; Akagi Y
    Arch Ophthalmol; 1998 Jun; 116(6):785-9. PubMed ID: 9639449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galactosemic neuropathy in transgenic mice for human aldose reductase.
    Yagihashi S; Yamagishi S; Wada R; Sugimoto K; Baba M; Wong HG; Fujimoto J; Nishimura C; Kokai Y
    Diabetes; 1996 Jan; 45(1):56-9. PubMed ID: 8522060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Sato S; Mori K; Wyman M; Kador PF
    Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities.
    Kowluru RA; Koppolu P
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3287-91. PubMed ID: 12356836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophils in galactose-fed dogs: suppressed apoptosis and increased adhesion to retinal capillary endothelial cells.
    Ohta N; Tsai JY; Secchi EF; Kador PF; Sato S
    J Diabetes Complications; 1999; 13(3):151-8. PubMed ID: 10509875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
    Das A; Frank RN; Zhang NL; Samadani E
    Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabeteslike preproliferative retinal changes in galactose-fed dogs.
    Takahashi Y; Wyman M; Ferris F; Kador PF
    Arch Ophthalmol; 1992 Sep; 110(9):1295-302. PubMed ID: 1520120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats.
    Robison WG; Laver NM; Jacot JL; Chandler ML; York BM; Glover JP
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1066-73. PubMed ID: 9152226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amelioration of diabetes-like retinal changes in galactose-fed dogs.
    Kador PF; Takahashi Y; Sato S; Wyman M
    Prev Med; 1994 Sep; 23(5):717-21. PubMed ID: 7845946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor.
    Takemoto DJ; Harris R; Brightman A; McGill J; Hua D; Davidson H; Fenwick B; Wagner LM
    Vet Ophthalmol; 2004; 7(3):163-7. PubMed ID: 15091323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.
    Ohguro N; Matsuda M; Ohashi Y; Fukuda M
    Br J Ophthalmol; 1995 Dec; 79(12):1074-7. PubMed ID: 8562538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mouse model of diabetic retinopathy.
    Kern TS; Engerman RL
    Arch Ophthalmol; 1996 Aug; 114(8):986-90. PubMed ID: 8694735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corneal endothelial morphology in the rat. Effects of aging, diabetes, and topical aldose reductase inhibitor treatment.
    Meyer LA; Ubels JL; Edelhauser HF
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):940-8. PubMed ID: 2967259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat is prevented by tolrestat.
    Forster HG; ter Wee PM; Hohman TC; Epstein M
    Diabetologia; 1996 Aug; 39(8):907-14. PubMed ID: 8858212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of aldose reductase inhibitor, CT-112, on sugar alcohol accumulation in corneal epithelium of galactose-fed rats.
    Awata T; Sogo S; Yamamoto Y
    Jpn J Ophthalmol; 1986; 30(3):245-50. PubMed ID: 3097363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabeteslike proliferative retinal changes in galactose-fed dogs.
    Kador PF; Takahashi Y; Wyman M; Ferris F
    Arch Ophthalmol; 1995 Mar; 113(3):352-4. PubMed ID: 7887849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Corneal endothelial evaluation of diabetic patients after phacoemulsification].
    Maadane A; Boutahar H; Bourakba S; Sekhsoukh R
    J Fr Ophtalmol; 2019 Apr; 42(4):381-386. PubMed ID: 30926269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of aldose reductase inhibitor CT-112 on the corneal epithelial barrier of galactose-fed rats.
    Yokoi N; Niiya A; Komuro A; Yokogaki S; Naka H; Awata T; Honma Y; Yamada J; Tei M; Kinoshita S
    Curr Eye Res; 1997 Jun; 16(6):595-9. PubMed ID: 9192169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia.
    Engerman RL; Kern TS
    Arch Ophthalmol; 1995 Mar; 113(3):355-8. PubMed ID: 7887850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.